Stock Chart
DNTH
Type: SELL wallstreet
Strike: $135
Premium: $10.00
Expiry: Apr 16, 2027
Target: $128
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About DNTH - Dianthus Therapeutics, Inc. Common Stock
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
Key Statistics
More DNTH Analysis
This DNTH stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track DNTH's price movements with trendlines, gamma walls, and key support/resistance levels.